CollPlant Biotechnologies Stock (NASDAQ: CLGN) stock price, news, charts, stock research, profile.
Open | $5.320 |
Close | $5.350 |
Volume / Avg. | 2.648K / 9.846K |
Day Range | 5.254 - 5.468 |
52 Wk Range | 4.220 - 8.900 |
Market Cap | $58.752M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 0.09% |
Days to Cover | 1.01 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CollPlant Biotechnologies (NASDAQ: CLGN) through any online brokerage.
Other companies in CollPlant Biotechnologies’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), Curis (NASDAQ:CRIS) and Intensity Therapeutics (NASDAQ:INTS).
The latest price target for CollPlant Biotechnologies (NASDAQ: CLGN) was reported by HC Wainwright & Co. on Thursday, November 30, 2023. The analyst firm set a price target for 11.00 expecting CLGN to rise to within 12 months (a possible 114.42% upside). 3 analyst firms have reported ratings in the last year.
The stock price for CollPlant Biotechnologies (NASDAQ: CLGN) is $5.13 last updated March 22, 2024 at 7:35 AM EDT.
There are no upcoming dividends for CollPlant Biotechnologies.
CollPlant Biotechnologies’s Q1 earnings are confirmed for Wednesday, May 22, 2024.
There is no upcoming split for CollPlant Biotechnologies.
CollPlant Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.